Dicerna Pharmaceuticals (United States)
0 sources
Financials
0001399529-21-000042Summary
Dicerna Pharmaceuticals (United States) is a business[1].
Key Facts
- Dicerna Pharmaceuticals (United States) is in the country of United States[2].
- Dicerna Pharmaceuticals (United States) is in the country of US[3].
- Dicerna Pharmaceuticals (United States)'s instance of is recorded as business[4].
- Dicerna Pharmaceuticals (United States)'s headquarters location is recorded as Cambridge[5].
- January 1, 2007 marks the founding of Dicerna Pharmaceuticals (United States)[6].
- Dicerna Pharmaceuticals (United States)'s official website is recorded as http://dicerna.com/[7].
- Dicerna Pharmaceuticals (United States)'s legal form is recorded as Delaware corporation[8].
- Dicerna Pharmaceuticals (United States)'s legal form is recorded as XTIQ[9].
Product Details
The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.
GLEIF Golden Copy — Level 1 entity data
-
Legal Entity Identifier (LEI): 549300CTZMJMPH28WN39[10]
-
Registered legal name: Dicerna Pharmaceuticals, Inc.[11]
-
Legal jurisdiction: US-DE[12]
-
GLEIF entity category: GENERAL[13]
-
Legal form (ISO 20275 ELF): XTIQ[14]
-
Entity status: ACTIVE[15]
-
LEI registration status: LAPSED[16]
-
LEI first registered: 2014-01-30[17]
-
LEI last updated: 2023-08-04[18]
-
LEI next renewal: 2018-04-14[19]
-
Managing LOU: 5493001KJTIIGC8Y1R12[20]
-
Registration authority: RA000602[21]
-
Authority entity ID: 4240086[22]
-
Other names: Oncorna Pharmaceuticals, Inc.[23]
-
Conformity flag: NON_CONFORMING[24]
Body
Founding
January 1, 2007 marks the founding of Dicerna Pharmaceuticals (United States)[6].
Operations
Dicerna Pharmaceuticals (United States)'s headquarters location is recorded as Cambridge[5].